In 2014, Andy and Maggie’s baby daughter, Greta, was dying. Diagnosed with acute lymphoblastic leukemia at just three months old, Greta barely survived chemotherapy and a bone marrow transplant. Now her cancer was back.
“We didn’t want her to suffer any more,” Andy said. “We found ourselves considering end-of-life care for our one-year-old daughter.”
But then, Greta qualified for the PLAT-02 immunotherapy trial, which has seen a 93 percent success rate. Immunotherapy involves reprogramming some of the body’s t cells to seek out and destroy cancer and is the treatment that inspired Strong Against Cancer.
“Immunotherapy just made sense to us,” said Andy. “We believed it could work.”
Greta was infused with her reprogrammed t cells and just weeks later was in complete remission.
“We thought we were going to lose our daughter,” Maggie said. “Today, she’s living a healthy, happy life.”
To learn about how you can support this groundbreaking research:
The first day of school is a milestone for any kid, but for #StrongAgainstCancer Greta, it's much more than that. Greta was one of our very first immunotherapy patients. She was so sick that her parents considered end-of-life care for their one-year-old daughter. After enrolling in Seattle Children's immunotherapy clinical trials, her cancer was in complete remission within weeks! Today, her mom says, "The first baby in Seattle to get immunotherapy starting kindergarten is a BIG deal!" Yes, it is!! Congratulations, Greta - our whole team is celebrating with you. 🎉💜💪